Company Overview
Snapshot
Founded in August 2012 by Tuvia Elbaum, Yitzi Kempinski, and Nir Blushtein, Umoove operates with 1–10 employees. The company has raised $2.75 million across four funding rounds from two investors. In April 2014, Umoove secured funding from investors including Bouaziz & Partners and Flint Capital, highlighting early investor confidence in its innovative eye-tracking technology.
Business overview
Umoove develops face and eye-tracking software designed for mobile devices, eliminating the need for additional hardware. Its core technology enables any device to interpret user gaze and facial movements, running efficiently with minimal CPU usage. The company's solutions are applicable across various markets, including gaming, advertising, and augmented/virtual reality, but hold particular significance in healthcare for analyzing brain activity related to conditions like ADHD, concussions, strokes, autism, and Parkinson’s disease. Umoove operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Medical Diagnostics, leveraging computer vision and artificial intelligence.
Strategic signal
In May 2021, Umoove launched an app designed to tackle mental health challenges, leveraging its proprietary eye-tracking technology. This development signals a strategic expansion beyond its core technology licensing into direct-to-consumer applications, demonstrating the company's commitment to applying its innovative solutions to address critical health issues and potentially opening new revenue streams in the digital health market.
Log in to access full profile ›Company Intelligence Q&A
- What is Umoove's primary technology?
- Umoove specializes in face and eye-tracking software that operates on mobile devices without requiring additional hardware. This technology utilizes unique algorithms and computer vision to interpret user gaze and facial movements.
- When was Umoove founded and by whom?
- Umoove was founded in August 2012 by Tuvia Elbaum, Yitzi Kempinski, and Nir Blushtein.
- How does Umoove's technology contribute to healthcare?
- Umoove's eye-tracking technology provides a window into analyzing brain activity, which can aid in observing conditions such as ADHD, concussions, strokes, autism, and Parkinson’s disease. The company has also developed an app to tackle mental health challenges, launched in May 2021.
- What is the patent status of Umoove's technology?
- Umoove's technology is built on unique algorithms, and the company has more than 15 patents pending.